Follow The Filings

PBH Prestige Consmr Healthcare

Health Care, filed as PRESTIGE CONSMR HEALTHCARE I (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 2.3%
  • $233M
  • 1 new 1 add

In 2026 Q2 Lee Ainslie opened a position in Prestige Consmr Healthcare, and John Rogers added.

Who owns this now

Largest portfolio weights among holders, up to 2.3% (John Rogers, Ariel Investments). Not free-float ownership.

  1. John Rogers Add 2.3%
  2. Lee Ainslie New 0.02%

Who owns PBH

Sorted by value, long equity only, as of 2026 Q2.

History
John Rogers, Ariel Investments 2.3% Add +13.9% 4,868,711 $230M History
Lee Ainslie, Maverick Capital 0.02% New 0.02% 50,975 $2.4M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PBH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PBH insider trades
  • None no insider bought on the open market
  • $310K sold by 2 insiders outside a trading plan
  • $114K sold by 1 insider under 10b5-1 plans
  1. Jeffrey Zerillo Senior VP Operations
    Planned sale
    $18K 351 shares at $52.28 0.8% of stake
    Traded May 11 Filed May 12
  2. Jeffrey Zerillo Senior VP Operations
    Planned sale
    $17K 305 shares at $54.36 0.7% of stake
    Traded May 7 Filed May 11
  3. Jeffrey Zerillo Senior VP Operations
    Sale
    $66K 1,207 shares at $54.99 2.7% of stake
    Traded May 5 Filed May 7
  4. Jeffrey Zerillo Senior VP Operations
    Planned sale
    $19K 346 shares at $55.32 0.8% of stake
    Traded May 5 Filed May 6
  5. Jeffrey Zerillo Senior VP Operations
    Sale
    $66K 1,000 shares at $65.93 2.4% of stake
    Traded Feb 11 Filed Feb 13
  6. Jeffrey Zerillo Senior VP Operations
    Planned sale
    $60K 1,000 shares at $60.00 2.3% of stake
    Traded Nov 28, 2025–Dec 1, 2025 Filed Dec 2, 2025
  7. John E Byom Director
    Sale
    $178K 3,000 shares at $59.35 5.5% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 share withholdings for taxes and 16 stock grants.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 5.02
8-K 2.02,7.01,9.01
10-Q
8-K 1.01,2.03,9.01
8-K/A 9.01
SCHEDULE 13G/A —
8-K 1.01,2.03,7.01,9.01
8-K/A 9.01
DEF 14A
8-K 1.01,2.01,2.03,8.01,9.01
10-K
8-K 1.01,2.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 1.01,7.01,8.01,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $1.13B $1.13B $1.14B $1.09B
Gross profit $625.29M $624.45M $634.46M $595.58M
Gross margin * 55.4% 55.5% 55.8% 54.7%
Net income -$82.31M $209.34M $214.6M $190.3M
Net margin * -7.3% 18.6% 18.9% 17.5%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $391.74M $375.04M $448.33M $431.48M
Total non-current assets * $2.96B $2.94B $2.95B $3.06B
Total assets $3.35B $3.32B $3.4B $3.49B
Total current liabilities $160.72M $117.05M $106.62M $120.92M
Total non-current liabilities * $1.75B $1.55B $1.46B $1.49B
Total equity $1.45B $1.66B $1.83B $1.89B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $229.72M $248.93M $251.52M $257.63M
Cash from investing -$11.58M -$20.11M -$17.45M -$136.84M
Cash from financing -$185.85M -$241.02M -$182.08M -$156.06M
Net change in cash $31.3M -$12.02M $51.42M -$34.02M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.